Michael Parini, EVP, CL&AO at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 47,222 shares at $248.52 ($11.6M) on 2020-02-11, disclosed to the SEC on 2020-02-12.
Seasonal sale ($11.6M) by EVP, CL&AO — this insider has traded VRTX in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $240.95 | 13,458 | $3.2M | 28.1% |
| 2 | $243.42 | 922 | $224K | 1.9% |
| 3 | $243.42 | 922 | $224K | 1.9% |
| 4 | $244.67 | 2,102 | $514K | 4.5% |
| 5 | $244.67 | 2,102 | $514K | 4.5% |
| 6 | $245.62 | 6,232 |
| $1.5M |
| 13.3% |
| 7 | $245.62 | 6,232 | $1.5M | 13.3% |
| 8 | $246.52 | 3,783 | $933K | 8.1% |
| 9 | $246.52 | 3,783 | $933K | 8.1% |
| 10 | $247.62 | 2,499 | $619K | 5.4% |
| 11 | $247.62 | 2,499 | $619K | 5.4% |
| 12 | $248.52 | 1,344 | $334K | 2.9% |
| 13 | $248.52 | 1,344 | $334K | 2.9% |
| Total | $244.64 avg | 47,222 | $11.6M | 100% |
| Filing → |
| VRTX | SELL | 2021-02-16 | $1.7M | — | Filing → |
| VRTX | SELL | 2021-02-09 | $415K | — | Filing → |
| VRTX | SELL | 2021-02-05 | $87K | — | Filing → |